5 completed. 2 Early Phase 1, 1 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow cevimeline: new trials by email Literature Review of cevimeline trials Research Report on cevimeline
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted Conditions Cevimeline - Dry Mouth | Early Phase 1 | Completed | Roxane Laboratories | 26 | 2009-02-01 | 2018-01-23 |
| Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed Conditions Cevimeline - Dry Mouth | Early Phase 1 | Completed | Roxane Laboratories | 27 | 2009-02-01 | 2018-01-23 |
| Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva Cevimeline, Pilocarpine - Dry Mouth | Not applicable | Completed | University of Kentucky | 15 | 2009-01-01 | 2018-06-04 |
| Study of the Effectiveness of Cevimeline on Oral Health in Patients With Radiation Induced Xerostomia Cevimeline - Xerostomia | Phase 4 | Completed | American Academy of Otolaryngology-Head and Neck Surgery Foundation | 54 | 2007-05-01 | 2014-05-22 |
| Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer cevimeline hydrochloride - Head and Neck Cancer, Oral Complications | Phase 3 | Completed | Daiichi Sankyo | 2001-06-01 | 2012-05-16 |
Xerostomia (4) · Esthesioneuroblastoma, Olfactory (1) · Head and Neck Neoplasms (1) · Radiation Injuries (1) · Salivary Gland Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
Roxane Laboratories (2) · American Academy of Otolaryngology-Head and Neck Surgery Foundation (1) · Daiichi Sankyo (1) · University of Kentucky (1)
United States (5)
Darin Brimhall, DO (2) · David Witsell, MD (1) · Joel Thompson, PhD (1) · Robert Vitti, MD (1)